PFIZER INC.

ABRILADA

Manufacturer:

PFIZER INC.

Abrilada HCPCS:

Q5132

HCPCS Code Descriptor:

Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg

Category:

Q Code

Abrilada NDCs:

00069-0328-02, 00069-0333-02, 00069-0325-01, 00069-0325-02

Primary Type:

Anti-TNF

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Abrilada:

ABRILADA is a Anti-TNF drug manufactured by PFIZER INC. and administered via the route of administration. The Q Code: Q5132 is aligned to the drug ABRILADA.

ACCESS PRICING AND MORE BY REGISTERING

Q5132 Added Date:

January 1, 2024

Q5132 Effective Date:

January 1, 2024

Q5132 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Abrilada billing and coding information.
Our team did not identify a source for Abrilada patient assistance information. Please reach out to our team if you feel that this is a mistake.
ABRILADA prescribing information can be found at the link below:
Information regarding ABRILADA’s side effects can be found at MedlinePlus